New Strategic Partnership with VectorBuilder for Optimized Custom Viral Vector Production
Univercells Technologies has formed a global strategic partnership with VectorBuilder to develop and optimize platform processes using innovative technologies, for intensified and continuous viral vector production for cell and gene therapies and vaccine applications. The companies will use the NevoLineTM Upstream platform and scale-XTM bioreactors at VectorBuilder’s GMP facility in Guangzhou, China, combining their capabilities to accelerate the scale-up of production to commercial scales to meet the growing demand for custom viral vectors.
Univercells Technologies and VectorBuilder have formed a strategic partnership in view of co-developing and optimizing protocols using innovative technologies for custom viral vector production for cell and gene therapies, as well as vaccine applications.
While there has been a significant rise in demand for custom viral vectors as a result of advances in cell and gene therapy and a growing interest in recombinant viral vaccines, catalysed by COVID-19, existing manufacturing technologies are unable to accommodate this rising demand. This partnership will combine the capabilities of both companies to address this issue, and maximize customers’ performance and success.
“With the complementarity of both companies’ expertise and know-how, we can maximize the benefits of our manufacturing technologies and offer an unparalleled solution for integrated continuous manufacture for VectorBuilder’s customers,” said Mathias Garny, CEO of Univercells Technologies.
The scale-X bioreactors and the NevoLine Upstream platform, employed for process optimization at VectorBuilder’s GMP Process Development facility in Guangzhou, China, provide high-performing production capacities while reducing footprint and costs. The comprehensive technology range will accelerate process development to enable a seamless transition to commercial manufacture.
About Univercells Technologies
Univercells Technologies provides innovative biomanufacturing technologies, offering a comprehensive technology portfolio to address the growing demand for viral vectors and viral vaccines. The company is committed to increasing customers’ performance while minimizing footprint and costs. For more information, visit: https://www.univercellstech.com/
VectorBuilder is a growing biotechnology company specializing in advanced genetic engineering solutions for research and medicine, and is a global leader in a range of products and services related to gene delivery. VectorBuilder has a comprehensive portfolio of offerings leveraging on its award-winning online platform for designing and ordering custom vectors. For more information, visit en.vectorbuilder.com and LinkedIn: VectorBuilder.